Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Apr 25;39(7):1492–1500. doi: 10.1161/ATVBAHA.119.312378

Table 2:

Vasomotor parameters and changes in response to vasoactive medications

Mean±SD %Change
Coronary Study
Coronary blood flow (mL/min)
 - Baseline
 - Acetylcholine infusion
 - Sodium nitroprusside infusion
 - Adenosine infusion
42±30
94±70
99±68
172±110

122±98%
152±84%
361±169%
Coronary vascular resistance (mmHg.mL −1.min)
 - Baseline
 - Acetylcholine infusion
 - Sodium nitroprusside infusion
 - Adenosine infusion
3.6±2.3
2.0±1.6
2.0±1.3
0.98±0.7

−46±23%
−59±15%
−75±9%
Coronary artery diameter (mm)
 - Baseline
 - Acetylcholine infusion
 - Sodium nitroprusside infusion
2.5±0.68
2.5±0.73
2.9±0.78

1.4±10%
19.4±16%
Femoral Study
Femoral blood flow velocity (cm/sec)
 - Baseline
 - Acetylcholine infusion
 - Sodium nitroprusside infusion
19±8
46±26
42±16

139±108%
124±57%
Femoral artery resistance (mmHg.mL −1.min)
 - Baseline
 - Acetylcholine infusion
 - Sodium nitroprusside infusion
5.9±2.3
2.8±1.6
2.3±0.9

−54±17%
−59±10%